| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.006 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.089 | 0.006 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.007 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.092 | 0.008 |